{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:46:02Z","timestamp":1792197962684,"version":"4.4.0"},"reference-count":199,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Uterine leiomyomas represent the most common benign gynecologic tumor. These hormone-dependent smooth-muscle formations occur with an estimated prevalence of ~70% among women of reproductive age and cause symptoms including pain, abnormal uterine bleeding, infertility, and recurrent abortion. Despite the prevalence and public health impact of uterine leiomyomas, available treatments remain limited. Among the potential causes of leiomyomas, early hormonal exposure during periods of development may result in developmental reprogramming via epigenetic changes that persist in adulthood, leading to disease onset or progression. Recent developments in unbiased high-throughput sequencing technology enable powerful approaches to detect driver mutations, yielding new insights into the genomic instability of leiomyomas. Current data also suggest that each leiomyoma originates from the clonal expansion of a single transformed somatic stem cell of the myometrium. In this review, we propose an integrated cellular and molecular view of the origins of leiomyomas, as well as paradigm-shifting studies that will lead to better understanding and the future development of non-surgical treatments for these highly frequent tumors.<\/jats:p>","DOI":"10.3390\/ijms22168483","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T21:49:41Z","timestamp":1628459381000},"page":"8483","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Molecular and Cellular Insights into the Development of Uterine Fibroids"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4052-7694","authenticated-orcid":false,"given":"Alba","family":"Machado-Lopez","sequence":"first","affiliation":[{"name":"Igenomix Foundation, INCLIVA Health Research Institute, 46980 Paterna, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Sim\u00f3n","sequence":"additional","affiliation":[{"name":"Igenomix Foundation, INCLIVA Health Research Institute, 46980 Paterna, Valencia, Spain"},{"name":"Department of Pediatrics, Obstetrics and Gynecology, Universidad de Valencia, 46010 Valencia, Spain"},{"name":"Department of Pediatrics, Obstetrics and Gynecology, BIDMC, Harvard University, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymara","family":"Mas","sequence":"additional","affiliation":[{"name":"Igenomix Foundation, INCLIVA Health Research Institute, 46980 Paterna, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: A systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.fertnstert.2013.02.017","article-title":"Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18\u201330 years old): A pilot study","volume":"99","author":"Marsh","year":"2013","journal-title":"Fertil. Steril."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/jwh.2018.7076","article-title":"Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women","volume":"27","author":"Marsh","year":"2018","journal-title":"J. Women\u2019s Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/01.AOG.0000188386.53878.49","article-title":"The FIBROID Registry: Symptom and quality-of-life status 1 year after therapy","volume":"106","author":"Spies","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejogrb.2010.05.012","article-title":"The burden of uterine fibroids in five European countries","volume":"152","author":"Downes","year":"2010","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nrc4015","article-title":"Precision medicine for cancer with next-generation functional diagnostics","volume":"15","author":"Friedman","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S1470-2045(15)00620-8","article-title":"Precision oncology: Origins, optimism, and potential","volume":"17","author":"Prasad","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","article-title":"Integrating liquid biopsies into the management of cancer","volume":"14","author":"Siravegna","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_10","first-page":"814","article-title":"Fibroids (uterine myomatosis, leiomyomas)","volume":"2015","author":"Lethaby","year":"2015","journal-title":"BMJ Clin. Evid."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ogc.2005.12.001","article-title":"Steroid hormones and leiomyomas","volume":"33","author":"Marsh","year":"2006","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"ref_12","first-page":"Cd005287","article-title":"Selective estrogen receptor modulators (SERMs) for uterine leiomyomas","volume":"10","author":"Deng","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_13","first-page":"Cd007687","article-title":"Mifepristone for uterine fibroids","volume":"8","author":"Tristan","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_14","first-page":"Cd008994","article-title":"Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy)","volume":"11","author":"Sangkomkamhang","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1289\/ehp.0901423","article-title":"Association of intrauterine and early-life exposures with diagnosis of uterine leiomyomata by 35 years of age in the Sister Study","volume":"118","author":"Baird","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/aje\/kwh016","article-title":"Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: A prospective study","volume":"159","author":"Wise","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/aje\/kws585","article-title":"Association of age at menarche with increasing number of fibroids in a cohort of women who underwent standardized ultrasound assessment","volume":"178","author":"Baird","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/GRF.0000000000000164","article-title":"Epidemiology of Uterine Fibroids: From Menarche to Menopause","volume":"59","author":"Wise","year":"2016","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"173184","DOI":"10.1155\/2013\/173184","article-title":"Uterine fibroids: Pathogenesis and interactions with endometrium and endomyometrial junction","volume":"2013","author":"Ciavattini","year":"2013","journal-title":"Obstet. Gynecol. Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bpobgyn.2015.11.015","article-title":"Hormones and pathogenesis of uterine fibroids","volume":"34","author":"Reis","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynecol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.fertnstert.2010.03.035","article-title":"Pregnancy-related fibroid reduction","volume":"94","author":"Laughlin","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmh019","article-title":"Sex steroidal regulation of uterine leiomyoma growth and apoptosis","volume":"10","author":"Maruo","year":"2004","journal-title":"Hum. Reprod. Update"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"943635","DOI":"10.1155\/2012\/943635","article-title":"Innovative oral treatments of uterine leiomyoma","volume":"2012","author":"Sabry","year":"2012","journal-title":"Obstet. Gynecol. Int."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Omar, M., Laknaur, A., Al-Hendy, A., and Yang, Q. (2019). Myometrial progesterone hyper-responsiveness associated with increased risk of human uterine fibroids. BMC Womens Health, 19.","DOI":"10.1186\/s12905-019-0795-1"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1210\/jc.2007-0725","article-title":"Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells","volume":"92","author":"Yin","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"BSR20190094","DOI":"10.1042\/BSR20190094","article-title":"Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2\/Beclin1-dependent mechanism","volume":"39","author":"Zhang","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/jc.2008-2093","article-title":"Progestins activate the AKT pathway in leiomyoma cells and promote survival","volume":"94","author":"Hoekstra","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.fertnstert.2020.12.011","article-title":"Mechanical stiffness augments ligand-dependent progesterone receptor B activation via MEK 1\/2 and Rho\/ROCK-dependent signaling pathways in uterine fibroid cells","volume":"116","author":"Islam","year":"2021","journal-title":"Fertil. Steril."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/humrep\/dep100","article-title":"Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial","volume":"24","author":"Engman","year":"2009","journal-title":"Hum. Reprod."},{"key":"ref_31","first-page":"Cd010770","article-title":"Selective progesterone receptor modulators (SPRMs) for uterine fibroids","volume":"4","author":"Murji","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0303-7207(02)00230-7","article-title":"Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells","volume":"196","author":"Hodges","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1210\/jc.2007-0823","article-title":"Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression","volume":"92","author":"Hassan","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/1097-4652(2000)9999:999<000::AID-JCP1040>3.0.CO;2-E","article-title":"17-beta estradiol elicits an autocrine leiomyoma cell proliferation: Evidence for a stimulation of protein kinase-dependent pathway","volume":"186","author":"Barbarisi","year":"2001","journal-title":"J. Cell. Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00428-008-0679-5","article-title":"Estrogen receptor alpha (ERalpha) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium","volume":"453","author":"Hermon","year":"2008","journal-title":"Virchows Arch."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.trsl.2013.11.008","article-title":"Estrogen-mediated activation of fibroblasts and its effects on the fibroid cell proliferation","volume":"163","author":"Luo","year":"2014","journal-title":"Transl. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"536346","DOI":"10.3389\/fonc.2021.536346","article-title":"LncRNA APTR Promotes Uterine Leiomyoma Cell Proliferation by Targeting ER\u03b1 to Activate the Wnt\/\u03b2-Catenin Pathway","volume":"11","author":"Zhou","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_38","first-page":"Cd009505","article-title":"Aromatase inhibitors for uterine fibroids","volume":"10","author":"Song","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-5122(00)00160-2","article-title":"Heritability and risk factors of uterine fibroids--the Finnish Twin Cohort study","volume":"37","author":"Luoto","year":"2000","journal-title":"Maturitas"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Ge, T., Chen, C.Y., Neale, B.M., Sabuncu, M.R., and Smoller, J.W. (2017). Phenome-wide heritability analysis of the UK Biobank. PLoS Genet., 13.","DOI":"10.1371\/journal.pgen.1006711"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000501335","article-title":"Estimating Uterine Fibroid SNP-Based Heritability in European American Women with Imaging-Confirmed Fibroids","volume":"84","author":"Bray","year":"2019","journal-title":"Hum. Hered."},{"key":"ref_42","first-page":"1875","article-title":"Genes control the cessation of a woman\u2019s reproductive life: A twin study of hysterectomy and age at menopause","volume":"83","author":"Snieder","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0020-7292(95)02533-I","article-title":"Familial predisposition to uterine leiomyomas","volume":"51","author":"Vikhlyaeva","year":"1995","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2188\/jea.12.249","article-title":"Familial aggregation of uterine myomas in Japanese women","volume":"12","author":"Sato","year":"2002","journal-title":"J. Epidemiol."},{"key":"ref_45","first-page":"663","article-title":"Family history as a risk factor for development of uterine leiomyomas. Results of a pilot study","volume":"47","author":"Romitti","year":"2002","journal-title":"J. Reprod. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/humrep\/dei049","article-title":"Familial prevalence of uterine fibroids is associated with distinct clinical and molecular features","volume":"20","author":"Okolo","year":"2005","journal-title":"Hum. Reprod."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.semcancer.2019.10.016","article-title":"Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research","volume":"61","author":"Ooi","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat. Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1158\/1078-0432.CCR-13-0304","article-title":"Molecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer","volume":"19","author":"Linehan","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/ng.805","article-title":"A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids","volume":"43","author":"Cha","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/aje\/kws276","article-title":"African ancestry and genetic risk for uterine leiomyomata","volume":"176","author":"Wise","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/jog.13217","article-title":"Replication of GWAS loci revealed the moderate effect of TNRC6B locus on susceptibility of Saudi women to develop uterine leiomyomas","volume":"43","author":"Bondagji","year":"2017","journal-title":"J. Obstet. Gynecol. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ajhg.2012.08.009","article-title":"Genome-wide linkage and association analyses implicate FASN in predisposition to Uterine Leiomyomata","volume":"91","author":"Eggert","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fgene.2015.00241","article-title":"Evaluation of GWAS candidate susceptibility loci for uterine leiomyoma in the multi-ethnic NIEHS uterine fibroid study","volume":"6","author":"Aissani","year":"2015","journal-title":"Front. Genet."},{"key":"ref_56","first-page":"9","article-title":"Genetic determinants of uterine fibroid size in the multiethnic NIEHS uterine fibroid study","volume":"6","author":"Aissani","year":"2015","journal-title":"Int. J. Mol. Epidemiol. Genet."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-0036-1585401","article-title":"Genetic Association Studies in Uterine Fibroids: Risk Alleles Presage the Path to Personalized Therapies","volume":"34","author":"Gallagher","year":"2016","journal-title":"Semin. Reprod. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"512940","DOI":"10.3389\/fgene.2020.512940","article-title":"Candidate Genes for Age at Menarche Are Associated With Uterine Leiomyoma","volume":"11","author":"Ponomarenko","year":"2020","journal-title":"Front. Genet."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1126\/science.1208930","article-title":"MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas","volume":"334","author":"Makinen","year":"2011","journal-title":"Science"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7150\/ijms.21856","article-title":"Analysis of MED12 Mutation in Multiple Uterine Leiomyomas in South Korean patients","volume":"15","author":"Lee","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1074\/jbc.RA118.001725","article-title":"Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8\/19","volume":"293","author":"Park","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3389\/fgene.2018.00552","article-title":"Expanded Somatic Mutation Spectrum of MED12 Gene in Uterine Leiomyomas of Saudi Arabian Women","volume":"9","author":"Ajabnoor","year":"2018","journal-title":"Front. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1073\/pnas.1917635117","article-title":"A precisely positioned MED12 activation helix stimulates CDK8 kinase activity","volume":"117","author":"Klatt","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1002\/jcp.30099","article-title":"Insights into the regulatory role and clinical relevance of mediator subunit, MED12, in human diseases","volume":"236","author":"Srivastava","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/ijc.28410","article-title":"Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas","volume":"134","author":"Vahteristo","year":"2014","journal-title":"Int. J. Cancer."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/humu.22612","article-title":"Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas","volume":"35","author":"Kampjarvi","year":"2014","journal-title":"Hum. Mutat."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1093\/hmg\/dds051","article-title":"Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: Transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity","volume":"21","author":"Hodge","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1172\/JCI81534","article-title":"Med12 gain-of-function mutation causes leiomyomas and genomic instability","volume":"125","author":"Mittal","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_69","first-page":"592","article-title":"Silencing Med12 Gene Reduces Proliferation of Human Leiomyoma Cells Mediated via Wnt\/\u03b2-Catenin Signaling Pathway","volume":"158","author":"Laknaur","year":"2017","journal-title":"Endocrinology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s43032-019-00084-7","article-title":"Introduction of Somatic Mutation in MED12 Induces Wnt4\/\u03b2-Catenin and Disrupts Autophagy in Human Uterine Myometrial Cell","volume":"27","author":"Ismail","year":"2020","journal-title":"Reprod. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fertnstert.2018.09.014","article-title":"Expression of erythropoietin messenger ribonucleic acid in wild-type MED12 uterine leiomyomas under estrogenic influence: New insights into related growth disparities","volume":"111","author":"Asano","year":"2019","journal-title":"Fertil. Steril."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.fertnstert.2014.06.040","article-title":"MED12 mutation frequency in unselected sporadic uterine leiomyomas","volume":"102","author":"Heinonen","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41598-017-01199-0","article-title":"Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas","volume":"7","author":"Heinonen","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.fertnstert.2016.10.035","article-title":"Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays","volume":"107","author":"Yatsenko","year":"2017","journal-title":"Fertil. Steril."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/gtmb.2010.0255","article-title":"Detection of somatic mutations and germline polymorphisms in mitochondrial DNA of uterine fibroids patients","volume":"15","author":"Shaik","year":"2011","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/gcc.2870130313","article-title":"A new cytogenetic subgroup in uterine leiomyoma is characterized by a deletion of the long arm of chromosome 3","volume":"13","author":"Moerman","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.1038\/sj.onc.1208784","article-title":"7q deletion mapping and expression profiling in uterine fibroids","volume":"24","author":"Vanharanta","year":"2005","journal-title":"Oncogene"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2004.08.025","article-title":"Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: Leiomyoma","volume":"158","author":"Sandberg","year":"2005","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0046-8177(91)90009-E","article-title":"Subgroups of uterine leiomyomas based on cytogenetic analysis","volume":"22","author":"Hu","year":"1991","journal-title":"Hum. Pathol."},{"key":"ref_80","first-page":"923","article-title":"Cytogenetic abnormalities in uterine leiomyomata","volume":"77","author":"Rein","year":"1991","journal-title":"Obstet. Gynecol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1447-0756.2009.01099.x","article-title":"Cytogenetic aberrations and the development of uterine leiomyomata","volume":"36","author":"Elsobky","year":"2010","journal-title":"J. Obstet. Gynecol. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"572.e1","DOI":"10.1016\/j.ajog.2014.01.011","article-title":"Uterine cellular leiomyomata with chromosome 1p deletions represent a distinct entity","volume":"210","author":"Hodge","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","article-title":"Massive genomic rearrangement acquired in a single catastrophic event during cancer development","volume":"144","author":"Stephens","year":"2011","journal-title":"Cell"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3389\/fgene.2019.00393","article-title":"On the Complexity of Mechanisms and Consequences of Chromothripsis: An Update","volume":"10","author":"Koltsova","year":"2019","journal-title":"Front. Genet."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.fertnstert.2014.06.050","article-title":"Genomics of uterine leiomyomas: Insights from high-throughput sequencing","volume":"102","author":"Mehine","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1302736","article-title":"Characterization of uterine leiomyomas by whole-genome sequencing","volume":"369","author":"Mehine","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"27595","DOI":"10.18632\/oncotarget.25137","article-title":"Malignant transformation of uterine leiomyoma to myxoid leiomyosarcoma after morcellation associated with ALK rearrangement and loss of 14q","volume":"9","author":"Holzmann","year":"2018","journal-title":"Oncotarget"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejogrb.2017.10.028","article-title":"Case of chromothripsis in a large solitary non-recurrent uterine leiomyoma","volume":"219","author":"Pendina","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1056\/NEJMc1310230","article-title":"Chromothripsis in uterine leiomyomas","volume":"369","author":"Markowski","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/gcc.10240","article-title":"HMGA2 expression in uterine leiomyomata and myometrium: Quantitative analysis and tissue culture studies","volume":"38","author":"Gross","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/gcc.20627","article-title":"Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease","volume":"48","author":"Klemke","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.fertnstert.2020.05.036","article-title":"HMGA2-mediated tumorigenesis through angiogenesis in leiomyoma","volume":"114","author":"Li","year":"2020","journal-title":"Fertil. Steril."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1096\/fj.202000520R","article-title":"An HMGA2-p62-ER\u03b1 axis regulates uterine leiomyomas proliferation","volume":"34","author":"Liu","year":"2020","journal-title":"FASEB J."},{"key":"ref_94","first-page":"19","article-title":"Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas","volume":"59","author":"Schoenmakers","year":"1999","journal-title":"Cancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1518752113","article-title":"Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers","volume":"113","author":"Mehine","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-4608(99)00054-0","article-title":"Expression of HMGIY in three uterine leiomyomata with complex rearrangements of chromosome 6","volume":"114","author":"Sornberger","year":"1999","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cancergencyto.2010.08.005","article-title":"6p21 rearrangements in uterine leiomyomas targeting HMGA1","volume":"203","author":"Nezhad","year":"2010","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0165-4608(99)00025-4","article-title":"Deletion 7q in uterine leiomyoma: Fluorescence in situ hybridization characterization on primary cytogenetic preparations","volume":"113","author":"Vanni","year":"1999","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/gcc.20427","article-title":"Definition of a minimal region of deletion of chromosome 7 in uterine leiomyomas by tiling-path microarray CGH and mutation analysis of known genes in this region","volume":"5","author":"Vanharanta","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_100","first-page":"469","article-title":"Genes associated with the genesis of leiomyoma of the uterus in a commonly deleted chromosomal region at 7q22","volume":"13","author":"Saito","year":"2005","journal-title":"Oncol. Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cancergencyto.2006.11.018","article-title":"Physical mapping of distinct 7q22 deletions in uterine leiomyoma and analysis of a recently annotated 7q22 candidate gene","volume":"174","author":"Ptacek","year":"2007","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/gcc.20692","article-title":"Identifying the molecular signature of the interstitial deletion 7q subgroup of uterine leiomyomata using a paired analysis","volume":"48","author":"Hodge","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/sj.onc.1201076","article-title":"Loss of heterozygosity and reduced expression of the CUTL1 gene in uterine leiomyomas","volume":"14","author":"Zeng","year":"1997","journal-title":"Oncogene"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ijc.10510","article-title":"Expression of N-terminally truncated isoforms of CDP\/CUX is increased in human uterine leiomyomas","volume":"100","author":"Moon","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/gcc.22001","article-title":"Identification of CUX1 as the recurrent chromosomal band 7q22 target gene in human uterine leiomyoma","volume":"52","author":"Schoenmakers","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1126\/science.8356449","article-title":"Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors","volume":"261","author":"Zhou","year":"1993","journal-title":"Science"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/hmg\/4.1.99","article-title":"Deletions of both alpha 5(IV) and alpha 6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours","volume":"4","author":"Heidet","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/jhg.2017.28","article-title":"Characterization of contiguous gene deletions in COL4A6 and COL4A5 in Alport syndrome-diffuse leiomyomatosis","volume":"62","author":"Nozu","year":"2017","journal-title":"J. Hum. Genet."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1933719115584449","article-title":"The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development","volume":"23","author":"Yang","year":"2016","journal-title":"Reprod. Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00404-017-4515-5","article-title":"Epigenetic and genetic landscape of uterine leiomyomas: A current view over a common gynecological disease","volume":"296","author":"Vergara","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e37110","DOI":"10.7554\/eLife.37110","article-title":"Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability","volume":"7","author":"Kuisma","year":"2018","journal-title":"Elife"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2741\/s424","article-title":"Epigenetic crosstalk: A molecular language in human metabolic disorders","volume":"7","author":"Sandoval","year":"2015","journal-title":"Front. Biosci. Sch."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2217\/fon.14.237","article-title":"Epigenetic alterations in cancer and personalized cancer treatment","volume":"11","author":"Miozzo","year":"2015","journal-title":"Future Oncol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/molehr\/gan045","article-title":"Potential link between estrogen receptor-alpha gene hypomethylation and uterine fibroid formation","volume":"14","author":"Asada","year":"2008","journal-title":"Mol. Hum. Reprod."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Navarro, A., Yin, P., Monsivais, D., Lin, S.M., Du, P., Wei, J.J., and Bulun, S.E. (2012). Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033284"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Maekawa, R., Sato, S., Yamagata, Y., Asada, H., Tamura, I., Lee, L., Okada, M., Tamura, H., Takaki, E., and Nakai, A. (2013). Genome-wide DNA methylation analysis reveals a potential mechanism for the pathogenesis and development of uterine leiomyomas. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066632"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/molehr\/gap010","article-title":"Aberrant DNA methylation status in human uterine leiomyoma","volume":"15","author":"Yamagata","year":"2009","journal-title":"Mol. Hum. Reprod."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2015.11.018","article-title":"The Epidemiology and Genetics of Uterine Leiomyoma","volume":"34","author":"Styer","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynecol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1016\/j.celrep.2019.11.077","article-title":"Integrated Epigenome, Exome, and Transcriptome Analyses Reveal Molecular Subtypes and Homeotic Transformation in Uterine Fibroids","volume":"29","author":"George","year":"2019","journal-title":"Cell Rep."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s10517-017-3870-3","article-title":"Differential DNA Hydroxymethylation in Human Uterine Leiomyoma Cells Depending on the Phase of Menstrual Cycle and Presence of MED12 Gene Mutations","volume":"163","author":"Pendina","year":"2017","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1038\/s41388-018-0612-6","article-title":"Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma","volume":"38","author":"Liu","year":"2019","journal-title":"Oncogene"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"bqaa172","DOI":"10.1210\/endocr\/bqaa172","article-title":"Towards an Epigenetic Treatment of Leiomyomas?","volume":"161","author":"Vaiman","year":"2020","journal-title":"Endocrinology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.semcdb.2009.10.007","article-title":"Histone methyltransferases in cancer","volume":"21","author":"Albert","year":"2010","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature08911","article-title":"Chromatin remodelling during development","volume":"463","author":"Ho","year":"2010","journal-title":"Nature"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in Polycomb-group silencing","volume":"298","author":"Cao","year":"2002","journal-title":"Science"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nature04431","article-title":"The Polycomb group protein EZH2 directly controls DNA methylation","volume":"439","author":"Brenner","year":"2006","journal-title":"Nature"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/1933719111398147","article-title":"Histone deacetylase 6 regulates estrogen receptor alpha in uterine leiomyoma","volume":"18","author":"Wei","year":"2011","journal-title":"Reprod. Sci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2119\/molmed.2014.00053","article-title":"Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy","volume":"21","author":"Borahay","year":"2015","journal-title":"Mol. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"10647","DOI":"10.1158\/0008-5472.CAN-07-1337","article-title":"Delta DNMT3B variants regulate DNA methylation in a promoter-specific manner","volume":"67","author":"Wang","year":"2007","journal-title":"Cancer Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/humupd\/dmu017","article-title":"MicroRNAs in the development and pathobiology of uterine leiomyomata: Does evidence support future strategies for clinical intervention?","volume":"20","author":"Karmon","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/s-0037-1606569","article-title":"Uterine Leiomyoma: New Perspectives on an Old Disease","volume":"35","author":"Segars","year":"2017","journal-title":"Semin. Reprod. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.fertnstert.2014.01.017","article-title":"Inhibition of canonical WNT signaling attenuates human leiomyoma cell growth","volume":"101","author":"Ono","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.fertnstert.2020.07.024","article-title":"Functional role of the long noncoding RNA X-inactive specific transcript in leiomyoma pathogenesis","volume":"115","author":"Chuang","year":"2021","journal-title":"Fertil. Steril."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.fertnstert.2020.09.143","article-title":"New epigenetic mechanism involved in leiomyoma formation","volume":"115","author":"Ciarmela","year":"2021","journal-title":"Fertil. Steril."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1126\/science.150.3692.67","article-title":"Glucose-6-phosphate dehydrogenase mosaicism: Utilization as a cell marker in the study of leiomyomas","volume":"150","author":"Linder","year":"1965","journal-title":"Science"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"18700","DOI":"10.1073\/pnas.0704472104","article-title":"Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells","volume":"104","author":"Ono","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.fertnstert.2012.04.044","article-title":"Identification and characterization of the human leiomyoma side population as putative tumor-initiating cells","volume":"98","author":"Mas","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dmu048","article-title":"Ovarian steroids, stem cells and uterine leiomyoma: Therapeutic implications","volume":"21","author":"Moravek","year":"2015","journal-title":"Hum. Reprod. Update"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/stem.2519","article-title":"Developmental Exposure to Endocrine Disruptors Expands Murine Myometrial Stem Cell Compartment as a Prerequisite to Leiomyoma Tumorigenesis","volume":"35","author":"Mas","year":"2017","journal-title":"Stem. Cells"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Ono, M., Qiang, W., Serna, V.A., Yin, P., Coon, J.S.t., Navarro, A., Monsivais, D., Kakinuma, T., Dyson, M., and Druschitz, S. (2012). Role of stem cells in human uterine leiomyoma growth. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0036935"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.fertnstert.2014.04.051","article-title":"Current understanding of somatic stem cells in leiomyoma formation","volume":"102","author":"Mas","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/molehr\/gau114","article-title":"Overexpression of the truncated form of High Mobility Group A proteins (HMGA2) in human myometrial cells induces leiomyoma-like tissue formation","volume":"21","author":"Mas","year":"2015","journal-title":"Mol. Hum. Reprod."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/modpathol.2013.243","article-title":"MED12 and HMGA2 mutations: Two independent genetic events in uterine leiomyoma and leiomyosarcoma","volume":"27","author":"Bertsch","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.mehy.2011.08.026","article-title":"Hypoxia: The driving force of uterine myometrial stem cells differentiation into leiomyoma cells","volume":"77","author":"Zhou","year":"2011","journal-title":"Med. Hypotheses"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-0032-1331801","article-title":"Somatic stem cells in the myometrium and in myomas","volume":"31","author":"Maruyama","year":"2013","journal-title":"Semin. Reprod. Med."},{"key":"ref_146","first-page":"317","article-title":"Serum vascular endothelial growth factor165 levels and uterine fibroid volume","volume":"84","author":"Chen","year":"2005","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1028-4559(08)60103-5","article-title":"Serum leptin levels in women with uterine leiomyomas","volume":"46","author":"Dingiloglu","year":"2007","journal-title":"Taiwan, J. Obstet. Gynecol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.fertnstert.2012.10.048","article-title":"Biomarkers in uterine leiomyoma","volume":"99","author":"Levy","year":"2013","journal-title":"Fertil. Steril."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1039\/C2MB05453A","article-title":"Proteomic identification of plasma biomarkers in uterine leiomyoma","volume":"8","author":"Lin","year":"2012","journal-title":"Mol. Biosyst."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Santulli, P., Borghese, B., Lemar\u00e9chal, H., Leconte, M., Millischer, A.E., Batteux, F., Chapron, C., and Borderie, D. (2013). Increased serum oxidative stress markers in women with uterine leiomyoma. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072069"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2018.07.031","article-title":"Assessment of oxidant-antioxidant status alterations with tumor biomarkers and reproductive system hormones in uterine MYOMAS","volume":"229","author":"Caglayan","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.fertnstert.2016.09.007","article-title":"Influence of vitamin D and transforming growth factor \u03b23 serum concentrations, obesity, and family history on the risk for uterine fibroids","volume":"106","author":"Ciebiera","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1177\/1933719116648219","article-title":"Serum YKL-40 Level Positively Correlates With Uterine Leiomyomas","volume":"23","author":"Guo","year":"2016","journal-title":"Reprod. Sci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mcp.2017.07.001","article-title":"Identification of TRADD as a potential biomarker in human uterine leiomyoma through iTRAQ based proteomic profiling","volume":"36","author":"Liu","year":"2017","journal-title":"Mol. Cell. Probes."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"102037","DOI":"10.1016\/j.jogoh.2020.102037","article-title":"Serum transforming growth factor \u03b2 and leucine-rich \u03b1-2-glycoprotein 1 as potential biomarkers for diagnosis of uterine leiomyomas","volume":"50","author":"Kamalipooya","year":"2021","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/IGC.0000000000000037","article-title":"Growth differentiation factor-15 as biomarker in uterine sarcomas","volume":"24","author":"Trovik","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_157","first-page":"370","article-title":"Potential role of preoperative serum CA125 for the differential diagnosis between uterine leiomyoma and uterine leiomyosarcoma","volume":"27","author":"Juang","year":"2006","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_158","first-page":"91","article-title":"Differences in the blood serum levels of soluble HLA-G concentrations between the menstrual cycle phases and menopause in patients with ovarian endometriosis and uterine leiomyoma","volume":"30","author":"Basta","year":"2009","journal-title":"Neuro-Endocrinol. Lett."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12943-017-0672-1","article-title":"Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors","volume":"16","author":"Makinen","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/bjc.2016.130","article-title":"MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas","volume":"114","author":"Mehine","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/ijc.27424","article-title":"MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups","volume":"131","author":"Markowski","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13039-015-0177-9","article-title":"A rare coincidence of different types of driver mutations among uterine leiomyomas (UL)","volume":"8","author":"Holzmann","year":"2015","journal-title":"Mol. Cytogenet."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ygyno.2018.07.007","article-title":"HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas","volume":"150","author":"Galindo","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"104284","DOI":"10.1016\/j.yexmp.2019.104284","article-title":"Identification of a novel diagnostic gene expression signature to discriminate uterine leiomyoma from leiomyosarcoma","volume":"110","author":"Adams","year":"2019","journal-title":"Exp. Mol. Pathol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/biolre\/ioy195","article-title":"Molecular differential diagnosis of uterine leiomyomas and leiomyosarcomas","volume":"101","author":"Mas","year":"2019","journal-title":"Biol. Reprod."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.fertnstert.2020.06.045","article-title":"Activation of protein kinase B by WNT4 as a regulator of uterine leiomyoma stem cell function","volume":"114","author":"Liu","year":"2020","journal-title":"Fertil. Steril."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41374-017-0020-5","article-title":"Inhibition of WNT\/\u03b2-catenin signaling under serum starvation and hypoxia induces adipocytic transdifferentiation in human leiomyoma cells","volume":"98","author":"Harada","year":"2018","journal-title":"Lab. Investig."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1210\/jc.2015-3555","article-title":"Vitamin D3 Inhibits Wnt\/\u03b2-Catenin and mTOR Signaling Pathways in Human Uterine Fibroid Cells","volume":"101","author":"Diamond","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.fertnstert.2018.10.008","article-title":"Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt\/\u03b2-catenin pathway","volume":"111","author":"Ferrero","year":"2019","journal-title":"Fertil. Steril."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/07853890.2014.912836","article-title":"PI3K\/AKT signaling pathway and cancer: An updated review","volume":"46","author":"Martini","year":"2014","journal-title":"Ann. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jsbmb.2006.08.006","article-title":"Phosphorylation of PTEN (phosphatase and tensin homologue deleted on chromosome ten) protein is enhanced in human fibromyomatous uteri","volume":"103","author":"Lengyel","year":"2007","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.fertnstert.2009.03.100","article-title":"Changes related to phosphatidylinositol 3-kinase\/Akt signaling in leiomyomas: Possible involvement of glycogen synthase kinase 3alpha and cyclin D2 in the pathophysiology","volume":"93","author":"Karra","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.fertnstert.2011.01.155","article-title":"All-trans-retinoic acid mediates changes in PI3K and retinoic acid signaling proteins of leiomyomas","volume":"95","author":"Shushan","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Lee, J.H., Choi, Y.S., Park, J.H., Kim, H., Lee, I., Won, Y.B., Yun, B.H., Seo, S.K., Lee, B.S., and Cho, S. (2019). MiR-150-5p May Contribute to Pathogenesis of Human Leiomyoma via Regulation of the Akt\/p27(Kip1) Pathway In Vitro. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112684"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/molehr\/gah002","article-title":"Molecular mechanisms involved in GnRH analogue-related apoptosis for uterine leiomyomas","volume":"10","author":"Bifulco","year":"2004","journal-title":"Mol. Hum. Reprod."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Ciebiera, M., W\u0142odarczyk, M., Wrzosek, M., M\u0119czekalski, B., Nowicka, G., \u0141ukaszuk, K., S\u0142abuszewska-J\u00f3\u017awiak, A., and Jakiel, G. (2017). Role of Transforming Growth Factor \u03b2 in Uterine Fibroid Biology. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18112435"},{"key":"ref_178","first-page":"913","article-title":"Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta","volume":"86","author":"Lee","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1210\/en.2004-1377","article-title":"Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta","volume":"146","author":"Luo","year":"2005","journal-title":"Endocrinology"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejogrb.2006.01.034","article-title":"Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth","volume":"130","year":"2007","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s13277-015-3813-4","article-title":"Transforming growth factor-\u03b2 signaling pathway cross-talking with ER\u03b1 signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro","volume":"37","author":"Shen","year":"2016","journal-title":"Tumour. Biol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2003.08.007","article-title":"The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy","volume":"209","author":"Chegini","year":"2003","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.fertnstert.2017.11.023","article-title":"Ulipristal acetate decreases transforming growth factor \u03b23 serum and tumor tissue concentrations in patients with uterine fibroids","volume":"109","author":"Ciebiera","year":"2018","journal-title":"Fertil. Steril."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.fertnstert.2018.12.026","article-title":"Ulipristal acetate decreases active TGF-\u03b23 and its canonical signaling in uterine leiomyoma via two novel mechanisms","volume":"111","author":"Lewis","year":"2019","journal-title":"Fertil. Steril."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41467-017-02602-0","article-title":"Integrative genomic and transcriptomic analysis of leiomyosarcoma","volume":"9","author":"Chudasama","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1464-410X.2009.08741.x","article-title":"Locally advanced prostate cancer: The role of surgical management","volume":"104","author":"Stratton","year":"2009","journal-title":"BJU Int."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: The mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nmeth.2639","article-title":"Smart-seq2 for sensitive full-length transcriptome profiling in single cells","volume":"10","author":"Picelli","year":"2013","journal-title":"Nat. Methods"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1101\/gr.191098.115","article-title":"The first five years of single-cell cancer genomics and beyond","volume":"25","author":"Navin","year":"2015","journal-title":"Genome Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nature21350","article-title":"Scaling single-cell genomics from phenomenology to mechanism","volume":"541","author":"Tanay","year":"2017","journal-title":"Nature"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nprot.2017.149","article-title":"Exponential scaling of single-cell RNA-seq in the past decade","volume":"13","author":"Svensson","year":"2018","journal-title":"Nat. Protoc."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"eaau5324","DOI":"10.1126\/science.aau5324","article-title":"Molecular, spatial, and functional single-cell profiling of the hypothalamic preoptic region","volume":"362","author":"Moffitt","year":"2018","journal-title":"Science"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41467-019-08831-9","article-title":"An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics","volume":"10","author":"Angelidis","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41586-018-0394-6","article-title":"A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte","volume":"560","author":"Plasschaert","year":"2018","journal-title":"Nature"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4155\/tde.12.144","article-title":"Nanomedicine for uterine leiomyoma therapy","volume":"4","author":"Ali","year":"2013","journal-title":"Ther. Deliv."},{"key":"ref_196","first-page":"50","article-title":"Effect of timing, dose and interstitial versus nanoparticle delivery of tumor necrosis factor alpha in combinatorial adjuvant cryosurgery treatment of ELT-3 uterine fibroid tumor","volume":"31","author":"Jiang","year":"2010","journal-title":"Cryo. Lett."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.fertnstert.2016.03.001","article-title":"Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cells","volume":"105","author":"Shalaby","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41467-020-14701-6","article-title":"Altered chromatin landscape and enhancer engagement underlie transcriptional dysregulation in MED12 mutant uterine leiomyomas","volume":"11","author":"Moyo","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"e1291","DOI":"10.1073\/pnas.1621150114","article-title":"Systematic dissection of genomic features determining transcription factor binding and enhancer function","volume":"114","author":"Grossman","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/16\/8483\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:41:57Z","timestamp":1760164917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/16\/8483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,6]]},"references-count":199,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["ijms22168483"],"URL":"https:\/\/doi.org\/10.3390\/ijms22168483","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,6]]}}}